Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network-based analysis
Asmaa Samy, Mohamed A. Maher, Nehal Adel Abdelsalam, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

A multi-omics approach for biomarker discovery in neuroblastoma: a network-based framework
Rahma Hussein, Ahmed M. Abou‐Shanab, Eman Badr
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine
Heba Mohamed Saad Eldien, Abdulrahman H. Almaeen, A Fath, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 229-229
Open Access
Predictive potential of SARS-CoV-2 RNA concentration in wastewater to assess the dynamics of COVID-19 clinical outcomes and infections
Raimundo Seguí, Rubén Cañas-Cañas, Jorge Casaña Mohedo, et al.
The Science of The Total Environment (2023) Vol. 886, pp. 163935-163935
Open Access | Times Cited: 12
Integrated analysis of RNA-seq datasets reveals novel targets and regulators of COVID-19 severity
Thais Teixeira Oliveira, Júlia Firme Freitas, Viviane Priscila Barros de Medeiros, et al.
Life Science Alliance (2024) Vol. 7, Iss. 4, pp. e202302358-e202302358
Open Access | Times Cited: 3
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections
Joshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Classification of COVID-19 Patients into Clinically Relevant Subsets by a Novel Machine Learning Pipeline Using Transcriptomic Features
Andrea R. Daamen, Prathyusha Bachali, Amrie C. Grammer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4905-4905
Open Access | Times Cited: 8
Bioinformatics and systems-biology approach to identify common pathogenic mechanisms for COVID-19 and systemic lupus erythematosus
Yinlan Wu, Yanhong Li, Yu Zhou, et al.
Autoimmunity (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 2
Metagenome sequence data mining for viral interaction studies: Review on progress and prospects
Mohammadreza Rahimian, Bahman Panahi
Virus Research (2024) Vol. 349, pp. 199450-199450
Open Access | Times Cited: 2
SARS-CoV-2 human challenge reveals single-gene blood transcriptional biomarkers that discriminate early and late phases of acute respiratory viral infections
Joshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Host genetic determinants of COVID‐19 susceptibility and severity: A systematic review and meta‐analysis
Setegn Eshetie, Pastor Jullian, Beben Benyamin, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Open Access | Times Cited: 5
Spatial transcriptomics unveils the in situ cellular and molecular hallmarks of the lung in fatal COVID-19
Carlos A. García‐Prieto, Eva Musulén, Verónica Dávalos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
In silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs
Neha Periwal, Urvashi Bhardwaj, Sankritya Sarma, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 8
Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
Silvia Martínez-Diz, Carmen María Morales-Álvarez, Yarmila Garcia-Iglesias, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Acute Kidney Injury (AKI) in COVID-19: In silico Identification of LncRNA-MiRNA-Gene Networks and Key Transcription Factors
Somayeh Hashemi Sheikhshabani, Zeinab Amini‐Farsani, Nesa Kazemifard, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 24, pp. 1907-1917
Closed Access | Times Cited: 4
Transcriptional Profiling of SARS-CoV-2-Infected Calu-3 Cells Reveals Immune-Related Signaling Pathways
Eric Petterson Viana Pereira, Stela Mirla da Silva Felipe, Raquel Martins de Freitas, et al.
Pathogens (2023) Vol. 12, Iss. 11, pp. 1373-1373
Open Access | Times Cited: 3
Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection
Cristian Arriaga-Canon, Laura Contreras-Espinosa, Rosa Rebollar‐Vega, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11058-11058
Open Access | Times Cited: 5
A brief review on the lessons learned from COVID-19 on drug discovery and research
Subodh Kumar, Hansraj Kumar, Joonmoni Lahon, et al.
Medicine and Pharmacy Reports (2024) Vol. 97, Iss. 3, pp. 243-248
Open Access
Ppidb: A Database for Protein-Protein Interactions
Preeti Pankajakshan, Yuktika Malhotra, Abhirami sunil, et al.
(2024)
Open Access
Application of TD-Based Unsupervised FE to Bioinformatics
Y‐h. Taguchi
Unsupervised and semi-supervised learning (2024), pp. 225-447
Closed Access
Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells
Zhe Liu, Olutomilayo Olayemi Petinrin, Nanjun Chen, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Targeting the Receptor Binding Domain and Heparan Sulfate Binding for Antiviral Drug Development against SARS-CoV-2 Variants
Zi-Sin Yang, Tzong-Shiun Li, Cheng‐Chung Chang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top